WCN25-4611 PREVALENCE & RISK FACTORS OF POST TRANSPLANT ERYTHOCYTOSIS: INITIAL RESULTS FROM RETROSPECTIVE STUDY AT A TRANSPLANT CENTRE IN NORTH-CENTRAL NIGERIA

Kidney transplantation remains the gold standard for treating end-stage kidney disease (ESKD), but it is associated with various complications. Post-transplant erythrocytosis (PTE), characterized by elevated hemoglobin (>17 g/dL) or hematocrit (>51%) following transplantation, affects 8-15% of recipients. Identifying factors contributing to PTE is critical for managing this condition effectively. This study aims to investigate the prevalence of PTE and associated risk factors in kidney transplant recipients at our center in North-central Nigeria.